Abstract: A control system for controlling an industrial robot and a method thereof. A control unit generates a control signal for controlling the motor. At least one drive unit controls the motor. The drive unit includes a switching unit adapted to convert DC current to alternating current to the motor in dependence on the control signal. A safety unit generates a stop signal for stopping the robot upon occurrence of a safety event. The drive unit disables the switching unit upon receiving the stop signal. The safety unit generates the stop signal with a time delay with respect to the safety event. The control unit generates the control signal in such a way that the motor is electrically braked during the time delay.

Abstract: A method for controlling a multi-axis industrial robot or manipulator arranged with a robot control unit. The robot or the control unit includes at least one first computer running a servo controller. A motion limit is configured for at least one axis of the robot arm. A reference signal for a robot position is sent to a robot controller together with a measurement of a position of the robot arm. The reference position is processed and the measured position and the processed reference position are then compared in an evaluator for the purpose of limiting the motion of an arm of the robot.

Abstract: The invention discloses an arrangement (100) in a base station in a cellular mobile telephony system, comprising a first plurality (120-160) of Printed Circuit Boards (PCB:s) and a second plurality of switches (110,190). Each of the PCB:s (120-160) in said first plurality is connected to each of the switches (110,190) in said second plurality. Each of the switches (110,190) is equipped with means for communicating with and polling each of the PCB:s (120-160) at predetermined intervals, said polling being with regard to the status of the PCB. The switches are equipped with means for distributing status information to the individual PCB:s as an outcome of said polling, and the PCB:s are equipped with means for communicating with each other via one, several, or all of the switches, and said communicating means in the PCB:s are arranged to choose routes of communication based on said status information received from the switches.

Abstract: The present invention relates to the use of an antisecretory protein or homologues thereof having the same properties, or certain fragments thereof in the manufacture of a medicament or a medical food for inducing improved rescue of injured or diseased nervous tissue, proliferation, apoptosis, differentiation and/or migration of an embryonic stem cell, adult stem cell, progenitor cell and/or a cell derived from a stem cell or progenitor cell, for treating a condition characterized by or associated with loss and/or gain of cells. In a preferred embodiment, the condition is a neurotrauma or a condition or disease of the CNS and/or PNS and/or ANS, for example, Alzheimer's disease.

Abstract: A method for controlling a multi-axis industrial robot or manipulator arranged with a robot control unit. The robot or the control unit includes at least one first computer running a servo controller. A motion limit is configured for at least one axis of the robot arm. A reference signal for a robot position is sent to a robot controller together with a measurement of a position of the robot arm. The reference position is processed and the measured position and the processed reference position are then compared in an evaluator for the purpose of limiting the motion of an arm of the robot.

Abstract: Technology is provided for the transfer of human blastocyst-derived stem cells (hBS cells) to a feeder-free culture system and propagation of the cells in such a feeder-free culture system, the method comprising the following steps of (a) transferring the blastocyst-derived stem cells from feeder to feeder free culture by mechanical treatment, (b) culturing the blastocyst-derived stem cells under feeder cell free growth conditions in a suitable growth medium and/or on a suitable support substrate, and (c) optionally passaging the blastocyst derived stem cell line every 3-10 days by enzymatic and/or mechanical treatment. The application of hBS cells cultured under a feeder-free condition in medicine (e.g., myocardial regeneration) and screening and toxicity testing also is provided.

Abstract: A control system for controlling an industrial robot including a manipulator. The control system includes a plurality of modules adapted to handle various functions. A first of the modules is a drive module adapted to control the motors driving the movements of the manipulator. A second of the modules is a main computer module adapted to execute a program with instructions for the movements of the manipulator and to plan the movements of the manipulator based on the executed instructions. The control system is adapted to communicate with one or more external devices via an external network. The control system includes an internal network. Each of the modules is arranged as a node in the internal network and includes communication elements for communicating with the other nodes in the internal network. The internal network includes a first part adapted for normal communication and a second part adapted for time critical communication.

Abstract: A method for the transfer of human blastocyst-derived stem cells (hBS cells) to feeder-free culture system and propagation of the cells in such a feeder-free culture system, the method comprising the following steps of (a) transferring the balstocyst-derived stem cells from feeder to feeder free culture by mechanical treatment, (b) optionally, culturing the blastocyst-derived stem cells under feeder cell free growth conditions in a suitable growth medium and/or on a suitable support substrate, and (c) optionally passaging the blastocyst derived stem cell line every 3-10 days by enzymatic and/or mechanical treatment. The invention also relates to the application of hBS cells cultured under feeder free condition in medicine (e.g., myocardial regeneration) and screening and toxicity tests.

Abstract: A system and method for changing safety-relevant data for a control device is provided wherein an authorized user inputs new or altered safety-relevant data, which is received on a data processing installation. A first checksum for the safety-relevant data is established and stored along with the safety-relevant data in at least one data record on the data processing installation. An enable code may also be stored in the at least one data record. This enable code may be produced by a code generator and encrypted by a key module. The data processing installation then reads back the safety-relevant data from a memory in the data processing installation, thereby allowing a comparison of the received safety-relevant data and the read back safety-relevant data. A second checksum is generated in a case where the comparison resulted in no differences. The second checksum may also be stored in the at least one data record.

Abstract: A control system for controlling one or more manipulators. One or more drives control motors driving the movements of the manipulator. An axis computer provides control signals to the drives. A main computer is adapted to execute a program with instructions for the movements and supplies the axis computer with control instructions. Physically separated modules are adapted to be placed at separated locations and to handle different functions. Each module may be surrounded by a casing of its own, may have its own power supply and has a well-defined interface in relation to the other modules. The computers and drives are arranged in the modules. One of the modules is a main computer module, which comprises the main computer. Another of the modules is a drive module, which comprises the axis computer.

Abstract: The field of the present invention is a novel neuroprotective peptide, pentinin, having neuroprotective properties. More particularly, the field of the present invention relates to the ability of pentinin (SEQ ID NO: 1) to affect endogenous undifferentiated stem cells to positively modulate neural damage and the use of such peptide for the treatment of disorders of the neural system. The present invention also relates to the manufacture of medicaments, methods of formulation and uses thereof. An intranasal delivery system for administration of pentinin is also described.

Abstract: An improved method for vitrification of biological cells, especially blastocyst-derived stem cells (BS cells). The method is very mild for the cells that remain viable after they have been thawed. The method comprises, i) transfer of the cells to a first solution (solution A), ii) optionally incubation of the cells in the first solution, iii) transfer the cells obtained in step i) or ii) to a second solution (solution B), iv) optionally incubation of the cells in the second solution, v) transfer of the cells obtained from step iii) or iv) into one or more closed straws with dimensions that allow a volume of at least 20 ?l to be contained in them vi) sealing the one or more closed straws, and vii) vitrification of the one or more closed straws. An important feature of the present invention is the use of closed straw and that relatively large volumes can be efficiently vitrified and subsequently thawed.

Abstract: The invention relates to a method for an industrial robot that comprises a manipulator and a control system comprising a processor and a computer program that influences the processor and is adapted to control a process, wherein the computer program comprises a plurality of cooperating objects (44), for addressing said objects (44).

Abstract: The invention discloses an arrangement (100) in a base station in a cellular mobile telephony system, comprising a first plurality (120-160) of Printed Circuit Boards (PCB:s) and a second plurality of switches (110,190). Each of the PCB:s (120-160) in said first plurality is connected to each of the switches (110,190) in said second plurality. Each of the switches (110,190) is equipped with means for communicating with and polling each of the PCB:s (120-160) at predetermined intervals, said polling being with regard to the status of the PCB. The switches are equipped with means for distributing status information to the individual PCB:s as an outcome of said polling, and the PCB:s are equipped with means for communicating with each other via one, several, or all of the switches, and said communicating means in the PCB:s are arranged to choose routes of communication based on said status information received from the switches.

Abstract: Use of rTMS having a range of stimuli frequency of 1-100 Hz, with 100-3000 pulses, given at each stimuli-session, and a stimulus intensity of 1-300 Ampere per microseconds, to induce certain electric fields in cells or tissue by the use of pulsed magnetic fields in healthy persons to modulate the proliferation, differentiation and/or migration of neural stem cells or progenitor cells in the adult central nervous system (CNS) especially in the hippocampal formation of dentate gyrus to improve memory and aid in improvement of stress-related syndromes, such as burnout.

Abstract: A rapid, simple and efficient method for the generation of neural progenitor cells from pluripotent/undifferentiated human blastocyst-derived stem (hBS) cells, neural progenitor cells obtained by the method and further differentiation of these cells into the three neural cell lineages, and the use of the neural progenitor cells and the differentiated cells in the preparation of medicaments. An important feature of the method is that neural progenitor cells are produced without a step involving formation of embryoid bodies (EB), improving the efficiency and the reducing the time for generation as compared to known methods.

Abstract: A method for the transfer of human blastocyst-derived stem cells (hBS cells) to feeder-free culture system and propagation of the cells in such a feeder-free culture system, the method comprising the following steps of (a) transferring the balstocyst-derived stem cells from feeder to feeder free culture by mechanical treatment, (b) optionally, culturing the blastocyst-derived stem cells under feeder cell free growth conditions in a suitable growth medium and/or on a suitable support substrate, and (c) optionally passaging the blastocyst derived stem cell line every 3-10 days by enzymatic and/or mechanical treatment. The invention also relates to the application of hBS cells cultured under feeder free condition in medicine (e.g., myocardial regeneration) and screening and toxicity tests.

Abstract: The present invention relates to the use of an antisecretory protein or homologues thereof having the same properties, or certain fragments thereof in the manufacture of a medicament or a medical food for inducing improved rescue of injured or diseased nervous tissue, proliferation, apoptosis, differentiation and/or migration of an embryonic stem cell, adult stem cell, progenitor cell and/or a cell derived from a stem cell or progenitor cell, for treating a condition characterized by or associated with loss and/or gain of cells. In a preferred embodiment, the condition is a neurotrauma or a condition or disease of the CNS and/or PNS and/or ANS, for example, Alzheimer's disease.

Abstract: A method, a use of the method, a system, a use of the system, a computer program code element, and a computer readable medium for automatically isolating primary faults out from a system log including actual error messages in a system controlled by an object oriented program. Messages are isolated through clustering.

Abstract: The invention relates to a method for permeabilization of a cell structure consisting of a single cell, an intracellular structure or an organelle comprising the following steps: (a) microelectrodes, preferably two carbon fiber electrodes or hollow fiber electrodes, are provided, (b) the microelectrodes are connected to a power supply, (c) the electrodes, individually controlled by high-graduation micromanipulators, are placed close to the cell structure at an appropriate inter-electrode distance, and (d) a highly focused electric field of a strength sufficient to obtain electroporation is applied between the electrodes. The method may be used in order to transfer cell impermeant solutes, such as drugs or genes, into the cell structure or out of the cell structure, in biosensors, in the treatment of tumours and neurodegenerative diseases and in the study of biophysical processes.